Cognitive dysfunction in cats. A syndrome we used to dismiss as 'old age'

Journal of Feline Medicine and Surgery

Volumn 12, Issue 11, 2010, Pages 837-848

  Landsberg, Gary M ^a   Denenberg, Sagi ^a   Araujo, Joseph A ^b  

^a North Toronto Animal Clinic   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANIMAL; BRAIN; CAT; CAT DISEASE; COGNITIVE DEFECT; PHYSIOLOGY; REVIEW; SYNDROME;

AGING; ANIMALS; BRAIN; CAT DISEASES; CATS; COGNITION DISORDERS; SYNDROME;

CANIS FAMILIARIS; FELIDAE;

EID: 77958472700     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2010.09.004     Document Type: Review

References (75)

1. Landsberg G.M., Hunthausen W., Ackerman L. The effects of aging on the behavior of senior pets. Handbook of behavior problems of the dog and cat 2003, 269-304. Saunders, Oxford, (Questionnaire Form 4 p 273; Fig 12.4, and form 10, p279; Fig 12.11). 2nd edn.
2. Chapman B., Voith V.L. Geriatric behavior problems not always related to age. DVM Newsmagazine 1987, 18:32-33.
3. Golini L., Clangeli R., Tranquillo V., Mariscoli M. Association between neurologic and cognitive dysfunction signs in a sample of aging dogs. J Vet Behav 2009, 4:25-30.
4. Nielson J.C., Hart B.L., Cliff K.D., Ruehl W.W. Prevalence of behavioral changes associated with age-related cognitive impairment in dogs. J Am Vet Med Assoc 2001, 218:1787-1791.
5. Osella M.C., Re G., Odore R., et al. Canine cognitive dysfunction syndrome: prevalence, clinical signs and treatment with a neuroprotective nutraceutical. Appl Anim Behav Sci 2007, 105:297-310.
6. Gunn-Moore D., Moffat K., Christie L.-A., Head E. Cognitive dysfunction and the neurobiology of aging in cats. J Small Anim Pract 2007, 48:546-553.
7. Milgram N.W., Head E., Weiner E., Thomas E. Cognitive functions and aging in the dog: acquisition of nonspatial visual tasks. Behav Neurosci 1994, 108:57-68.
8. Cummings B.J., Satou T., Head E., et al. Diffuse plaques contain C-terminal A beta 42 and not A beta 40: evidence from cats and dogs. Neurobiol Aging 1996, 17:653-659.
9. Cummings B.J., Head E., Afagh A.J., Milgram N.W., Cotman C.W. Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol Learn Mem 1996, 66:11-23.
10. Tapp P.D., Siwak C.T., Gao F.Q., et al. Frontal lobe volume, function, and beta-amyloid pathology in a canine model of aging. J Neurosci 2004, 24:8205-8213.
11. Borras D., Ferrer I., Pumarola M. Age related changes in the brain of the dog. Vet Pathol 1999, 36:202-211.
12. Colle M.-A., Hauw J.-J., Crespau F., et al. Vascular and parenchymal beta-amyloid deposition in the aging dog: correlation with behavior. Neurobiol Aging 2000, 21:695-704.
13. Salvin H.E., McGreevy P.D., Sachev P.S., Valenzuela M.J. Under diagnosis of canine cognitive dysfunction; a cross-sectional survey of older companion dogs. Vet J 2010, 184:277-281.
14. Tapp P.D., Siwak C.T., Estrada J., et al. Size and reversal learning in the beagle dog as a measure of executive function and inhibitory control in aging. Learn Mem 2003, 10:64-73.
15. Milgram N.W., Zicker S.C., Head E., et al. Dietary enrichment counteracts age-associated cognitive dysfunction in canines. Neurobiol Aging 2002, 23:737-745.
16. Studzinski C.M., Araujo J.A., Milgram N.W. The canine model of human cognitive aging and dementia: pharmacological validity of the model for assessment of human cognitive-enhancing drugs. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:489-498.
17. Studzinski C.M., Christie L.A., Araujo J.A., et al. Visuospatial function in the beagle dog: an early marker of cognitive decline in a model of human aging and dementia. Neurobiol Learn Mem 2006, 86:197-204.
18. Araujo J.A., Studzinski C.M., Head E., Cotman C.W., Milgram N.W. Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging. Age 2005, 27:27-37.
19. Levine M.S., Lloyd R.L., Fisher R.S., Hull C.D., Buchwald N.A. Sensory, motor and cognitive alterations in aged cats. Neurobiol Aging 1987, 8:253-263.
20. Levine M.S., Lloyd R.L., Hull C.D., Fisher R.S., Buchwald N.A. Neurophysiological alterations in caudate neurons in aged cats. Brain Res 1987, 401:213-230.
21. Harrison J., Buchwald J. Eyeblink conditioning deficits in the old cat. Neurobiol Aging 1983, 4:45-51.
22. Epstein M., Kuehn N., Landsberg G., et al. AAHA Senior Care Guidelines for Dogs and Cats. J Am Anim Hosp Assoc 2005, 41:81-91.
23. Pittari J., Rodan I., Beekman G., et al. American Association of Feline Practitioners Senior Care Guidelines. J Feline Med Surg 2009, 11:763-778. Also available at. http://www.catvets.com.
24. Landsberg G.L., Araujo J.A. Behavior problems in geriatric pets. Vet Clin N Am Small Anim Pract 2005, 35:675-698.
25. de Rivera C, Dobson H, Denenberg S, Landsberg GM, Araujo JA, Milgram B. Longitudinal magnetic resonance spectroscopy changes in aged beagle dogs [abstract]. In: Heath SE, ed. 7th International Veterinary Behaviour Meeting, Edinburgh, ESVCE, Belgium, 2009; 108-110.
26. Zhang C., Hua T., Zhu Z., Luo X. Age related changes of structures in cerebellar cortex of cat. J Biosci 2006, 31:55-60.
27. Pugliese M., Cangitano C., Ceccariglia S., et al. Canine cognitive dysfunction and the cerebellum: acetylcholinesterase reduction, neuronal and glial changes. Brain Res 2007, 1139:85-94.
28. Araujo J.A., Studzinski C.M., Milgram N.W. Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:411-422.
29. Milgram N.W., Ivy G.O., Head E., et al. The effect of l-deprenyl on behavior, cognitive function, and biogenic amines in the dog. Neurochem Res 1993, 18:1211-1219.
30. Zhang J.H., Sampogna S., Morales F.R., Chase M.H. Age-related changes in cholinergic neurons in the laterodorsal and the pedunculo-pontine tegmental nuclei of cats: a combined light and electron microscopic study. Brain Res 2005, 1052:47-55.
31. Chase M.H. Sleep patterns in old cats. Sleep disorders: basic and clinical research 1983, 445-448. Spectrum Publications, New York. M.H. Chase (Ed.).
32. Head E., Liu J., Hagen T.M., et al. Oxidative damage increases with age in a canine model of human brain aging. J Neurochem 2002, 82:375-381.
33. Shigengana M.K., Hagen T.M., Ames B.N. Oxidative damage and mitochondrial decay in aging. Proc Nat Acad Sci USA 1994, 91:10771-10778.
34. Nakamura S., Nakayama H., Kiatipattanasakul W., Uetsuka K., Uhcida K., Goto N. Senile plaques in very aged cats. Acta Neuropathol 1996, 91:437-439.
35. Head E., McCleary R., Hahn F.F., Milgram N.W., Cotman C.W. Region-specific age at onset of beta-amyloid in dogs. Neurobiol Aging 2000, 21:89-96.
36. Pugliese M., Mascort J., Mahy N., Ferrer I. Diffuse beta-amyloid plaques and hyperphosphorylated tau are unrelated processes in aged dogs with behavioral deficits. Acta Neuropathol 2006, 112:175-183.
37. Brellou G., Vlemmas I., Lekkas S., Papaioannou N. Immunohistochemical investigation of amyloid beta protein (Abeta) in the brain of aged cats. Histol Histopathol 2005, 20:725-731.
38. Gunn-Moore D.A., McVee J., Bradshaw J.M., Pearson G.R., Head E., Gunn-Moore F.J. Beta amyloid and hyper-phosphorylated tau deposition in cat brains. J Feline Med Surg 2006, 8:234-242.
39. Head E., Moffat K., Das P., et al. Beta-amyloid deposition and tau phosphorylation in clinically characterized aged cats. Neurobiol Aging 2005, 26:749-763.
40. Kuroki K., Uchida K., Kiatipattanasakul W., et al. Immunohistochemical detection of tau proteins in various non-human animal brains. Neuropathol 1997, 17:174-180.
41. Solomon P.R., Beal M.F., Pendlebury M.W. Age-related disruption of classical conditioning: a models systems approach to memory disorders. Neurobiol Aging 1988, 9:535-546.
42. McCune S., Stevenson J., Fretwell L., Thompson A., Mills D.S. Aging does not significantly affect performance in a spatial learning task in the domestic cat (Felis silvestris catus). Appl Anim Behav Sci 2008, 3:345-356.
43. Milgram N.W. Cognitive experience and its effect on age-dependent cognitive decline in beagle dogs. Neurochem Res 2007, 28:1677-1682.
44. Siwak C.T., Tapp P.D., Milgram N.W. Effect of age and level of cognitive function on spontaneous and exploratory behaviors in the Beagle dog. Learn Mem 2001, 8:65-70.
45. Milgram N.W., Head E., Zicker S.C., et al. Long-term treatment with antioxidants and a program of behavioral enrichment reduces age-dependent impairment in discrimination and reversal learning in beagle dogs. Exp Gerontol 2004, 39:753-765.
46. Araujo J.A., Chan A.D.F., Winka L.L., Seymour P.A., Milgram N.W. Dose-specific effects of scopolamine on canine cognition: impairment of visuospatial memory, but not visuospatial discrimination. Psychopharmacol 2004, 175:92-98.
47. Pan Y., Larson B., Araujo J.A., et al. Dietary supplementation with medium-chain TAG has long-lasting cognition-enhancing effects in aged dogs. Br J Nutr 2010, 103:1746-1754.
48. Head E. Combining an antioxidant-fortified diet with behavioral enrichment leads to cognitive improvement and reduced brain pathology in aging canines: strategies for healthy aging. Ann N Y Acad Sci 2007, 1114:398-406.
49. Chan A.D., Nippak P.M., Murphey H., et al. Visuospatial impairments in aged canines (Canis familiaris): the role of cognitive-behavioral flexibility. Behav Neurosci 2002, 116:443-454.
50. Milgram N.W., Adams B., Callahan H., et al. Landmark discrimination learning in the dog. Learn Mem 1999, 6:54-61.
51. Christie L.-A., Studzinski C.M., Araujo J.A., et al. Age-dependent spatial learning deficits: characterization of egocentric and allocentric spatial learning in the beagle dog. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:361-369.
52. Milgram NW. Neuropsychologicalfunction and aging in cats. Proceedings of the 15th annual conference on canine cognition and aging; 2010 November 10-12; Laguna Beach, CA, USA.
53. McMillan F.D. Maximizing quality of life in ill animals. J Am Anim Hosp Assoc 2003, 39:227-235.
54. Hetts S., Heinke M.L., Estep D.Q. Behavioral wellness concepts for general practice. J Am Vet Med Assoc 2004, 225:506-513.
55. Barberger-Gateau P., Raffaitin C., Letenneur L., et al. Dietary patterns and risk of dementia: the three-city cohort study. Neurol 2007, 69:1921-1930.
56. Taha A.Y., Henderson S.T., Burnham W.M. Dietary enrichment with medium chain-triglycerides (AC-1203) elevates poly unsaturated fatty acids in the parietal cortex of aged dogs; implications for treating age-related cognitive decline. Neurochem Res 2009, 34:1619-1625.
57. Studzinski C.M., MacKay W.A., Beckett T.L., et al. Induction of ketosis may improve mitochondrial function and decrease steady-state amyloid-beta precursor protein (APP) levels in the aged dog. Brain Res 2008, 21:209-217.
58. Cupp C.J., Jean Philippe C., Kerr W.W., Patial A.R., Perez-Camargo G. Effect of nutritional interventions on longevity of senior cats. Int J App Res Med 2006, 4:34-50.
59. Houpt K., Levine E., Landsberg G., Moffat K.S., Zicker S.C. Antioxidant fortified food improves owner perceived behavior in the aging cat. Proceedings of the ESFM Feline Conference 2007, Czech Republic, Prague.
60. Messonier S.P. Cognitive disorder (senility). The natural health bible for dogs and cats 2001, 56-57. Prima Publishing, Roseville.
61. Trevizan L., de Mello Kessler A., Bigley K.E., Anderson W.H., Waldron M.I., Bauer J.E. Effects of dietary medium-chain triglycerides on plasma lipids and lipoprotein distribution and food aversion in cats. Am J Vet Res 2010, 71:435-440.
62. Cena F, Colangeli R, Fassola F, et al. Effect of a combination of phosphatidylserine, ginkgo biloba, vitamin E and pyridoxine on clinical signs of brain ageing; a pilot multicentric study. Proceedings of the 2nd Annual Meeting of the European College of Veterinary Behavioural Medicine for Companion Animals & the 11th Annual Meeting of the European Society of Veterinary Clinical Ethology 2005; 2: 127-135.
63. Heath S.E., Barabas S., Craze P.G. Nutritional supplementation in cases of canine cognitive dysfunction - a clinical trial. Appl Anim Behav Sci 2007, 105:274-283.
64. Araujo J.A., Landsberg G.M., Milgram N.W., Miolo A. Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, Ginkgo biloba, vitamin E and pyridoxine. Can Vet J 2008, 49:379-385.
65. Raitieri M., Caviglia A.M., Marchi M., et al. Changes of neurotransmitter release in the old rat brain and effects of phosphatidylserine treatment. New trends in aging research 1988, 21-26. Liviana Press, Padua. G. Pepeu, B. Tomlinson, C.M. Wischik (Eds.).
66. White H.L., Scates P.W., Cooper B.R. Extracts of Ginkgo biloba leaves inhibit monoamine oxidase. Life Sci 1996, 58:1315-1321.
67. Dakshinamurti K., Paulose C.S., Siow Y.L. Neurobiology of pyridoxine. Vitamin B6: its role in health and disease 1995, 99-121. Alan R Liss, New York. R.D. Reynolds, J.E. Leklem (Eds.).
68. Marambaud P., Zhao H., Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 2005, 280:37377-37382.
69. Bottiglieri T. S-Adenosyl-L-methionine (SAMe): from the bench to the bedside - molecular basis of a pleiotrophic molecule. Am J Clin Nutr 2002, 76(suppl):1151S-1157S.
70. Rème C.A., Dramard V., Kern L., Hofmans J., Halsberhe C., Mombiela D.V. Effect of S-adenosylmethionine tablets on the reduction of age-related mental decline in dogs: a double-blind placebo-controlled trial. Vet Ther 2008, 9:69-82.
71. Ruehl W.W., Bruyette W.W., DePaoli D.S., et al. Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia, and Alzheimer's disease: clinical presentation, cognitive testing, pathology and response to l-deprenyl therapy. Prog Brain Res 1995, 106:217-225.
72. Campbell S., Trettien A., Kozan B. A noncomparative open-label study evaluating the effect of selegiline hydrochloride in a clinical setting. Vet Ther 2001, 2:24-39.
73. Landsberg G. Therapeutic options for cognitive decline in senior pets. J Am Anim Hosp Assoc 2006, 42:407-413.
74. Parkinson F.E., Rudophi K.A., Fredholm B.B. Propentofylline: a nucleoside transport inhibitor with neuroprotective effects in cerebral ischemia. Gen Pharmacol 1994, 25:1053-1058.
75. Hill A.S., Werner J.A., Rogers Q.R., O'Neill S.L., Christopher M.M. Lipoic acid is 10 times more toxic in cats than reported in humans, dogs or rats. J Anim Physiol Anim Nutr 2004, 88:150-156.